Lack of Association between the S20G Missense Mutation of Amylin Gene and Essential Hypertension in Korean Population

  • Kang, Byung-Yong (Seoulin Bioscience Institute, Seoulin Bioscience, Co., Ltd.) ;
  • Bae, Joon-Seol (Seoulin Bioscience Institute, Seoulin Bioscience, Co., Ltd.) ;
  • Kim, Jae-Hyoun (Dept. of Health Science, College of Natural Science, Dongduk Womens University) ;
  • Om, Ae-Son (College of Human Ecology, Hanyang University) ;
  • Ryu, Jae-Chun (Toxicology Lab., Korea Institute of Science and Technology) ;
  • Eo, Hyun-Seon (School of Biological Science, Seoul National University) ;
  • Shin, Jae-Hyun (School of Biological Science, Seoul National University) ;
  • Shin, Jung-Hee (School of Biological Science, Seoul National University) ;
  • Lee, Chung-Choo (School of Biological Science, Seoul National University) ;
  • Kim, Ki-Tae (Seoulin Bioscience Institute, Seoulin Bioscience, Co., Ltd.)
  • Published : 2001.09.01

Abstract

Essential hypertension is a heterogeneously multifactorial disease in which blood pressure is harmfully high without overt cause. Both genetic and environmental factors have been implicated in its etiology. In view of the regulatory role of this peptide in the carbohydrate metabolism and renin-angiotensin system, amylin gene has been proposed to a candidate gene for essential hypertension. Therefore, we scanned the amylin gene for mutations in 133 Korean normotensives and 61 essential hypertensives by single-strand conformational polymorphism, and found a single heterozygous S20G missense mutation. However, no significant difference was observed between normotensives and essential hypertensives in the distribution of allele and genotype frequencies of this mutation at the amylin gene (P>0.05). This finding suggests that S20G missense mutation of the amylin gene are unlikely to contribute to the etiology of essential hypertension in the Korean population.

Keywords